Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease (Q44728792)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease (English)

1 reference

Europe PubMed Central

5 December 2017

Alzheimer's disease

0 references

3

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

Rudolph E. Tanzi

5

object named as

Rudolph E Tanzi

1 reference

Europe PubMed Central

5 December 2017

Sandra M Payton

4

object named as

Sandra M Payton

1 reference

Europe PubMed Central

5 December 2017

1

object named as

Seiichi Nagano

1 reference

Europe PubMed Central

5 December 2017

author name string

Xudong Huang

2

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

14 January 2004

1 reference

Europe PubMed Central

5 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

5 December 2017

279

1 reference

Europe PubMed Central

5 December 2017

15

1 reference

Europe PubMed Central

5 December 2017

14673-14678

1 reference

Europe PubMed Central

5 December 2017

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Oxidative and hydrolytic properties of beta-amyloid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Tyrosyl radicals in prostaglandin H synthase-1 and -2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313003200

21 January 2018

Identifiers

10.1074/JBC.M313003200

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44728792&oldid=2034674098"